Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):223-4.